Cogan-Like Syndrome Following Nivolumab Immunotherapy for Metastatic Cutaneous Melanoma
- 24 June 2024
- journal article
- research article
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 32 (10) , 2553-2557
Abstract
To report a case of Cogan-Like Syndrome following treatment with nivolumab for metastatic cutaneous melanoma. A case report. A 54-year-old female sought a second opinion from us regarding the recently diagnosed uveitis in both eyes. She had a diagnosis of metastatic cutaneous melanoma in the right arm and was undergoing treatment with nivolumab. Four weeks following the initiation of nivolumab therapy, she experienced tinnitus and bilateral sensorineural hearing loss, which was treated with oral and intratympanic steroids. While tapering the oral steroids, she developed iridocyclitis with papillitis in both eyes. This combination of vestibuloauditory symptoms and ocular inflammation was strikingly reminiscent of Cogan's syndrome. Because of the timing in relation to the nivolumab therapy and the steroid responsiveness of her presentation, this was speculated to be due to immune overactivation from the nivolumab. Given her complex condition, which involved toxicity and multiple metastases, the patient was advised to consider either topical and/or local corticosteroids or intravenous immunoglobulin. The patient chose to persist with corticosteroid therapy. Nivolumab could potentially be linked to an immune-related condition resembling Cogan syndrome. In cases involving patients with a complex condition necessitating nivolumab treatment, the use of topical and/or local corticosteroids or intravenous immunoglobulin, might constitute the sole viable treatment options.Keywords
Funding Information
- funding associated
This publication has 21 references indexed in Scilit:
- Unilateral acute anterior uveitis with macular edema following the use of sildenafil citrate in a patient with HLA-B27 positivityAmerican Journal of Ophthalmology Case Reports, 2021
- Uso de fármacos inmunomoduladores en una consulta de uveítisReumatología Clínica, 2019
- PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse EventsJAMA Oncology, 2019
- Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic MalignanciesOcular Immunology and Inflammation, 2019
- Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade InhibitionOcular Immunology and Inflammation, 2019
- Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature reviewAutoimmunity Reviews, 2017
- Vogt-Koyanagi-Harada diseaseSurvey of Ophthalmology, 2017
- Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International WorkshopAmerican Journal of Ophthalmology, 2005
- Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysisOcular Immunology and Inflammation, 2000
- SYNDROME OF NONSYPHILITIC INTERSTITIAL KERATITIS AND VESTIBULOAUDITORY SYMPTOMSArchives of Ophthalmology (1950), 1945